Therefore, the results of these in vivo experiments verified that hepatocyte GSDMD mediated HMGB1 release and subsequently regulated endothelial GSDMD-mediated vascular injury in endotoxemia. This evidence concerns the gene HMGB1 and serum lipopolysaccharide activity.